SMTL ID : 6ohs.2 (3 other biounits)

Structure of compound 3 (ML299) bound human Phospholipase D2 catalytic domain

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.20 Å

Oligo State

monomer

Ligands

1 x MJY: 4-bromo-N-{(2S)-1-[1-(3-fluorophenyl)-4-oxo-1,3,8-triazaspiro[4.5]decan-8-yl]propan-2-yl}benzamide(Non-covalent)

MJY.1: 18 residues within 4Å: Chain A: W.71, W.72, L.116, G.117, I.118, A.147, H.149, R.171, L.221, W.226, W.247, Q.349, F.350, G.393, Y.461, N.480, R.484, D.491 18 PLIP interactions: 18 interactions with chain A Hydrophobic interactions: A:W.71, A:W.71, A:W.71, A:W.72, A:W.72, A:L.116, A:L.116, A:I.118, A:L.221, A:W.226, A:W.226, A:W.247, A:Y.461 Hydrogen bonds: A:R.171, A:R.171, A:Q.349, A:G.393, A:N.480

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Metrick, C.M. et al., Human PLD structures enable drug design and characterization of isoenzyme selectivity. Nat.Chem.Biol. (2020)

Release Date

2020-02-19

Peptides

Phospholipase D2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Phospholipase D2

Related Entries With Identical Sequence